Blog
RSS FeedPosted by Michael Wonder on 23 May 2019
Drugs and money
24 May 2019 - An extra $60 million for PHARMAC over the next four years will benefit more than 30,000 New ...
Posted by Michael Wonder on 23 May 2019
Guyon Espiner investigates PHARMAC: the secret list
24 May 2019 - Desperate patients are being left in the dark as to when PHARMAC will fund medicines. Guyon Espiner ...
Posted by Michael Wonder on 22 May 2019
Guyon Espiner investigates PHARMAC: The NZ Buyer’s Club
23 May 2019 - Guyon Espiner reveals how lung cancer patients are buying cut-price drugs from India, as other New Zealanders ...
Posted by Michael Wonder on 21 May 2019
Official Information Act response: PrEP data
20 May 2019 - PHARMAC responds to a request for information relating to the funding of tenofovir disoproxil fumarate with ...
Posted by Michael Wonder on 21 May 2019
Official Information Act response: adrenaline auto-injector cost utility analysis
20 May 2019 - PHARMAC responds to a request for any cost utility analyses performed by PHARMAC in relation to ...
Posted by Michael Wonder on 19 May 2019
Cost of EpiPens putting children at risk, specialists say
19 May 2019 - Children with life-threatening allergies whose families cannot afford to pay for EpiPen auto-injectors are at serious ...
Posted by Michael Wonder on 14 May 2019
PHARMAC publishes list of applications to be considered by PTAC later this month
14 May 2019 - The list includes a number of medicines for patients with breast cancer. ...
Posted by Michael Wonder on 12 May 2019
'It’s absurd' - allergy sufferers beg PHARMAC to fund EpiPens
13 May 2019 - An ice cream factory in the family sounds like every child’s dream. But for Dylan Wright, just ...
Posted by Michael Wonder on 08 May 2019
PTAC recommends the use of pembrolizumab as a first-line treatment for patients with advanced non-small cell lung cancer
8 May 2019 - The focus now shifts to when will the PTAC recommendation be implemented. ...
Posted by Michael Wonder on 08 May 2019
New hope for cancer patients accessing leading-edge unfunded drugs
8 May 2019 - Peter Fergusson, CEO of Leukaemia & Blood Cancer New Zealand is heartened to hear that Pharmac ...
Posted by Michael Wonder on 08 May 2019
Blood cancer patients advocate pleads for treatment funding
8 May 2019 - Patient advocacy group Myeloma New Zealand has joined forces with other patient groups to petition Parliament ...
Posted by Michael Wonder on 07 May 2019
RFP - supply of the levonorgestrel intrauterine system
6 May 2019 - PHARMAC invites proposals for the supply of the levonorgestrel intrauterine system in New Zealand. ...
Posted by Michael Wonder on 07 May 2019
Cancer sufferers deliver eight PHARMAC funding petitions to Parliament
7 May 2019 - People desperately seeking cancer treatment which could extend their lives by years have called on politicians to ...
Posted by Michael Wonder on 07 May 2019
Hundreds rally at Parliament to present petitions for better PHARMAC funding
7 May 2019 - Deputy Prime Minister and New Zealand First leader Winston Peter has thrown his weight behind trialling ...
Posted by Michael Wonder on 06 May 2019
'Well-being' budget should fund cancer treatment
7 May 2019 - Hundreds of cancer patients and survivors will turn up at Parliament today to protest against Pharmac, ...